Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology

BACKGROUND: Microarrays have revolutionized breast cancer (BC) research by enabling studies of gene expression on a transcriptome-wide scale. Recently, RNA-Sequencing (RNA-Seq) has emerged as an alternative for precise readouts of the transcriptome. To date, no study has compared the ability of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fumagalli, Debora, Blanchet-Cohen, Alexis, Brown, David, Desmedt, Christine, Gacquer, David, Michiels, Stefan, Rothé, Françoise, Majjaj, Samira, Salgado, Roberto, Larsimont, Denis, Ignatiadis, Michail, Maetens, Marion, Piccart, Martine, Detours, Vincent, Sotiriou, Christos, Haibe-Kains, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289354/
https://www.ncbi.nlm.nih.gov/pubmed/25412710
http://dx.doi.org/10.1186/1471-2164-15-1008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289354/
https://www.ncbi.nlm.nih.gov/pubmed/25412710
http://dx.doi.org/10.1186/1471-2164-15-1008

Ejemplares similares